scholarly journals Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data

2014 ◽  
Vol 69 (10) ◽  
pp. 2835-2840 ◽  
Author(s):  
G. G. Zhanel ◽  
K. D. Wolter ◽  
C. Calciu ◽  
P. Hogan ◽  
D. E. Low ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Streptococcus Pneumoniae ◽  
Respiratory Tract ◽  
Clinical Cure ◽  
Respiratory Tract Infections ◽  
Clinical Trial Data ◽  
Trial Data ◽  
Phase 3 ◽  
Tract Infections ◽  
Cure Rates

Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial

Homeopathy ◽  
2016 ◽  
Vol 105 (1) ◽  
pp. 71-77 ◽  
Author(s):  
Camila Monteiro Siqueira ◽  
Fortune Homsani ◽  
Venício Féo da Veiga ◽  
Carlos Lyrio ◽  
Haroldo Mattos ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Controlled Clinical Trial ◽  
Acute Respiratory Tract Infections ◽  
Tract Infections

scholarly journals Antimicrobial Resistance of 1,113Streptococcus pneumoniae Isolates from Patients with Respiratory Tract Infections in Spain: Results of a 1-Year (1996–1997) Multicenter Surveillance Study

1999 ◽  
Vol 43 (2) ◽  
pp. 357-359 ◽  
Author(s):  
Fernando Baquero ◽  
José Angel García-Rodríguez ◽  
Juan García de Lomas ◽  
Lorenzo Aguilar ◽  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Antimicrobial Resistance ◽  
Respiratory Tract ◽  
Middle Ear ◽  
Respiratory Tract Infections ◽  
Surveillance Study ◽  
High Frequencies ◽  
Resistant Strains ◽  
Tract Infections

A nationwide susceptibility surveillance of 1,113Streptococcus pneumoniae isolates was carried out and found the following percentages of resistance: cefuroxime, 46%; penicillin, 37%; macrolides, 33%; aminopenicillins, 24%; cefotaxime, 13%; and ceftriaxone, 8%. A significant (P < 0.05) seasonality pattern for β-lactam antibiotics was observed. Resistance to macrolides was higher (P < 0.05) in middle-ear samples. Higher percentages of resistance to cefuroxime and macrolides were observed among penicillin-intermediate and -resistant strains, whereas high frequencies of resistance to aminopenicillins and expanded-spectrum cephalosporins were observed only among penicillin-resistant strains.

Prospective Clinical Trial on the Efficacy of Amoxycillin Administered Twice or Four Times Daily in Children with Respiratory Tract Infections

1981 ◽  
Vol 9 (4) ◽  
pp. 274-276 ◽  
Author(s):  
F D Daschner ◽  
U Behre ◽  
A Dalhoff
Keyword(s):  
Clinical Trial ◽  
Body Weight ◽  
Respiratory Tract ◽  
Lower Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Lower Respiratory Tract Infections ◽  
Duration Of Therapy ◽  
Daily Dose ◽  
Tract Infections ◽  
To Receive

Thirty-four children with upper or lower respiratory tract infections were randomly allocated to receive either a twice daily or four times daily dose of 50 mg amoxycillin/kg body-weight/day. Mean duration of therapy was identical in both groups. Peak and trough antibiotic concentrations were determined. Eradication of bacteria, clinical improvement and side-effects were comparable in both groups.

Sign in / Sign up

Export Citation Format

Share Document